SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $44,668,600 | +1254.3% | 368,492 | +1179.5% | 1.06% | +1375.0% |
Q2 2023 | $3,298,176 | -86.1% | 28,800 | -83.2% | 0.07% | -85.2% |
Q1 2023 | $23,660,311 | +3854.8% | 171,663 | +3618.1% | 0.48% | +3364.3% |
Q4 2022 | $598,271 | -62.8% | 4,617 | -68.3% | 0.01% | -65.0% |
Q3 2022 | $1,609,000 | +35.1% | 14,561 | -8.4% | 0.04% | +29.0% |
Q2 2022 | $1,191,000 | -69.2% | 15,890 | -63.0% | 0.03% | -65.9% |
Q4 2021 | $3,872,000 | +16.3% | 43,000 | +19.4% | 0.09% | -1.1% |
Q3 2021 | $3,329,000 | +665.3% | 36,000 | +542.9% | 0.09% | +557.1% |
Q2 2021 | $435,000 | +86.7% | 5,600 | +186.0% | 0.01% | -39.1% |
Q1 2019 | $233,000 | -77.7% | 1,958 | -93.7% | 0.02% | -89.4% |
Q2 2017 | $1,045,000 | -3.5% | 31,000 | -15.3% | 0.22% | +7.4% |
Q1 2017 | $1,083,000 | +286.8% | 36,600 | +258.8% | 0.20% | +215.6% |
Q4 2016 | $280,000 | -41.8% | 10,200 | +30.3% | 0.06% | -38.5% |
Q3 2016 | $481,000 | -49.0% | 7,830 | -83.8% | 0.10% | -71.2% |
Q1 2016 | $943,000 | – | 48,300 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 2,999,453 | $413,414,607 | 13.31% |
Casdin Capital, LLC | 1,160,000 | $159,882,800 | 13.17% |
Ikarian Capital, LLC | 271,300 | $37,393,279 | 8.48% |
Avoro Capital Advisors LLC | 3,650,000 | $503,079,500 | 7.46% |
Evolutionary Tree Capital Management, LLC | 36,190 | $4,988,068 | 6.91% |
Finepoint Capital LP | 122,757 | $16,919,597 | 6.46% |
Ikarian Capital, LLC | 205,400 | $28,310,282 | 6.42% |
Boxer Capital, LLC | 775,000 | $106,818 | 5.25% |
Ghost Tree Capital, LLC | 125,000 | $17,229,000 | 5.09% |
Logos Global Management LP | 220,000 | $30,322,600 | 4.34% |